Oncolys BioPharma, Inc.'s total assets for Q2 2025 were ¥1.93B, a decrease of -16.51% from the previous quarter. JP:4588 total liabilities were ¥493.35M for the fiscal quarter, a 31.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.